Icecure Medical Valuation

ICCM Stock  USD 1.48  0.01  0.68%   
Based on Macroaxis valuation methodology, the firm appears to be undervalued. Icecure Medical retains a regular Real Value of $1.93 per share. The prevalent price of the firm is $1.48. Our model calculates the value of Icecure Medical from evaluating the firm fundamentals such as Return On Asset of -0.53, shares outstanding of 56.57 M, and Return On Equity of -1.11 as well as inspecting its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Icecure Medical's valuation include:
Price Book
8.5472
Enterprise Value
75.8 M
Enterprise Value Ebitda
(2.63)
Price Sales
22.6523
Enterprise Value Revenue
20.6483
Undervalued
Today
1.48
Please note that Icecure Medical's price fluctuation is very risky at this time. Calculation of the real value of Icecure Medical is based on 3 months time horizon. Increasing Icecure Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Icecure stock is determined by what a typical buyer is willing to pay for full or partial control of Icecure Medical. Since Icecure Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Icecure Stock. However, Icecure Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  1.48 Real  1.93 Target  3.37 Hype  1.49 Naive  1.57
The intrinsic value of Icecure Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Icecure Medical's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
1.93
Real Value
5.61
Upside
Estimating the potential upside or downside of Icecure Medical helps investors to forecast how Icecure stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Icecure Medical more accurately as focusing exclusively on Icecure Medical's fundamentals will not take into account other important factors:
Earnings
Estimates (0)
LowProjectedHigh
-0.07-0.07-0.07
Details
Hype
Prediction
LowEstimatedHigh
0.071.495.17
Details
Naive
Forecast
LowNext ValueHigh
0.031.575.24
Details
3 Analysts
Consensus
LowTarget PriceHigh
3.063.373.74
Details
Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Icecure Medical's intrinsic value based on its ongoing forecasts of Icecure Medical's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Icecure Medical's closest peers.

Icecure Medical Cash

9.31 Million

Icecure Valuation Trend

Knowing Icecure Medical's actual value is paramount for traders when making sound investment determinations. Using both Icecure Medical's enterprise value as well as its market capitalization is the best way to estimate the value of the company and is usually enough for investors to make market timing decisions.

Icecure Medical Total Value Analysis

Icecure Medical is currently forecasted to have valuation of 75.8 M with market capitalization of 83.16 M, debt of 599 K, and cash on hands of 17.73 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Icecure Medical fundamentals before making equity appraisal based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
75.8 M
83.16 M
599 K
17.73 M

Icecure Medical Investor Information

About 49.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.28. Icecure Medical had not issued any dividends in recent years. The entity had 1:8 split on the 9th of August 2021. Icecure Medical is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April.

Icecure Medical Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Icecure Medical has an asset utilization ratio of 19.68 percent. This suggests that the Company is making $0.2 for each dollar of assets. An increasing asset utilization means that Icecure Medical is more efficient with each dollar of assets it utilizes for everyday operations.
 
Covid

Icecure Medical Ownership Allocation

Icecure Medical has a total of 56.57 Million outstanding shares. Icecure Medical secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Icecure Medical Profitability Analysis

The company reported the previous year's revenue of 3.23 M. Net Loss for the year was (14.65 M) with profit before overhead, payroll, taxes, and interest of 1.6 M.

About Icecure Medical Valuation

We use absolute and relative valuation methodologies to arrive at the intrinsic value of Icecure Medical. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Icecure Medical based exclusively on its fundamental and basic technical indicators. By analyzing Icecure Medical's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Icecure Medical's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Icecure Medical. We calculate exposure to Icecure Medical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Icecure Medical's related companies.
Last ReportedProjected for Next Year
Gross Profit1.5 M957.4 K
Pretax Profit Margin(4.08)(4.29)
Operating Profit Margin(4.34)(4.56)
Net Loss(4.08)(4.29)
Gross Profit Margin 0.36  0.28 

Icecure Medical Growth Indicators

Investing in growth stocks can be very risky. If the company such as Icecure Medical does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding45.6 M

Icecure Medical Current Valuation Indicators

Icecure Medical's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Icecure Medical's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Icecure Medical, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Icecure Medical's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Icecure Medical's worth.
When determining whether Icecure Medical is a strong investment it is important to analyze Icecure Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Icecure Medical's future performance. For an informed investment choice regarding Icecure Stock, refer to the following important reports:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Icecure Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
To learn how to invest in Icecure Stock, please use our How to Invest in Icecure Medical guide.
You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Icecure Medical. If investors know Icecure will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Icecure Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.28)
Revenue Per Share
0.076
Quarterly Revenue Growth
1.024
Return On Assets
(0.53)
Return On Equity
(1.11)
The market value of Icecure Medical is measured differently than its book value, which is the value of Icecure that is recorded on the company's balance sheet. Investors also form their own opinion of Icecure Medical's value that differs from its market value or its book value, called intrinsic value, which is Icecure Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Icecure Medical's market value can be influenced by many factors that don't directly affect Icecure Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Icecure Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Icecure Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Icecure Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.